Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
Impact of Resident Participation in Post-ICU Follow Up Clinic
for
Professional Burnout
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05713669
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase3, Recruiting
Registry Study for Radiation Therapy Outcomes
for
Neoplasms
Location: New York NY, Somerset NJ, Hampton VA, Baltimore MD,
Sponsor: Proton Collaborative Group
Sex: All
Age: 0+
Code: NCT01255748
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
for
Mild Cognitive Impairment, Alzheimer's Disease,
Location: East Providence RI, Delray Beach FL, Atlantis FL,
Sponsor: GAP Innovations, PBC
Sex: All
Age: 60 - 70+
Code: NCT06584357
Recruiting
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Southfield MI
Sponsor: St. John Providence Health System
Sex: All
Age: 18+
Code: NCT00150657
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Miami FL, Charleston SC,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase1, Phase2, Recruiting
Asciminib Roll-over Study
for
Chronic Myelogenous Leukemia,
Location: New York NY, Montreal, Ann Arbor MI, Milwaukee WI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 7 - 70+
Code: NCT04877522
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Halifax, Boston MA, New Haven NY, Albany NY,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Boston MA, Burlington MA, Hartford CT, Springfield MA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase2, Recruiting
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder